지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2024.5
- 수록면
- 256 - 262 (7page)
- DOI
- https://doi.org/10.4111/icu.20230389
이용수
초록· 키워드
오류제보하기
Purpose: We evaluated the risk factors associated with failure to complete gemcitabine–cisplatin (GP) neoadjuvant chemotherapy (NAC) for muscle-invasive bladder cancer (MIBC).
Materials and Methods: In total, 231 patients with MIBC treated with NAC before undergoing radical cystectomy between 2013 and 2022 participated in this study. Logistic regression analysis was performed to assess the relationship between the likelihood of incomplete NAC and clinical and demographic variables, including age, sex, hypertension (HTN), diabetes mellitus (DM), prechemotherapy glomerular filtration rate, clinical T stage, clinical N stage, and body mass index (BMI).
Results: Of 231 patients, 209 (90.5%) and 22 (9.5%) completed and discontinued the NAC course, respectively. The mean age was 66.13±9.15, 65.63±9.07, and 70.86±8.66 years for the total sample, continuation, and discontinuation groups, respectively (p=0.010). No significant inter-group differences in sex, HTN, height, weight, BMI, pre-chemotherapy glomerular filtration rate, clinical T stage, or clinical N stage were observed. According to the results of the multivariable analysis, age (odds ratio [OR] 1.076, 95% confidence interval [CI] 1.013–1.143, p=0.018) and the presence of DM (OR 2.541, 95% CI 1.028–6.281, p=0.043) were significantly associated with NAC discontinuation.
Conclusions: Thus, older age and presence of DM are potential risk factors for GP NAC discontinuation in patients with MIBC. Further studies are required to validate our findings and develop strategies to minimize the rate of GP NAC discontinuation in this population.
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Determinants of neoadjuvant chemotherapy use in muscle-invasive bladder cancer
Investigative and Clinical Urology
2020 .01
-
Trends in the Use of Chemotherapy before and after Radical Cystectomy in Patients with Muscle-invasive Bladder Cancer in Korea
Journal of Korean Medical Science
2015 .01
-
A Single-Center, Retrospective Study of Bevacizumab-Containing Neoadjuvant Chemotherapy followed by Interval Debulking Surgery for Ovarian Cancer
Yonsei Medical Journal
2020 .01
-
Impact of Molecular Subtype Conversion of Breast Cancers after Neoadjuvant Chemotherapy on Clinical Outcome
Cancer Research and Treatment
2016 .01
-
Impact of increased utilization of neoadjuvant chemotherapy on survival in patients with advanced ovarian cancer: experience from a comprehensive cancer center
Journal of Gynecologic Oncology
2018 .01
-
Neoadjuvant Chemotherapy in Asian Patients With Locally Advanced Gastric Cancer
Journal of Gastric Cancer
2023 .01
-
[Breast] Risk Factors of Breast Cancer Recurrence in Pathologic Complete Response (pCR) Achieved Post Neoadjuvant Chemotherapy (NAC) Patients
대한외과학회 학술대회 초록집
2022 .11
-
Neoadjuvant Chemotherapy-Guided Bladder-Sparing Treatment for Muscle-Invasive Bladder Cancer: Results of a Pilot Phase II Study
Cancer Research and Treatment
2021 .10
-
Impact of Neoadjuvant Chemotherapy on the Local Recurrence in Breast Cancer Patients with Clinical T2
대한외과학회 학술대회 초록집
2021 .05
-
Perioperative systemic therapy in muscle invasive bladder cancer: Current standard method, biomarkers and emerging strategies
Investigative and Clinical Urology
2023 .05
-
Neoadjuvant Cisplatin-Based Chemotherapy Followed by Selective Bladder Preservation Chemoradiotherapy in Muscle-Invasive Urothelial Carcinoma of the Bladder: Post Hoc Analysis of Two Prospective Studies
Cancer Research and Treatment
2024 .07
-
Neoadjuvant chemotherapy with gemcitabine and cisplatin followed by selective bladder preservation chemoradiotherapy in muscle-invasive urothelial carcinoma of bladder
Investigative and Clinical Urology
2022 .03
-
Decrease of peripheral blood lymphocyte count predicts response to neoadjuvant chemotherapy in breast cancer patients
KOREAN JOURNAL OF CLINICAL ONCOLOGY
2020 .12
-
Development of Machine Learning-Based Model and Nomogram for Prediction of Pathological Complete Response after Neoadjuvant Chemoterapy in Advanced Breast Cancer
대한외과학회 학술대회 초록집
2021 .05
-
Trends in utilization of neoadjuvant and adjuvant chemotherapy for muscle invasive bladder cancer
Investigative and Clinical Urology
2020 .01
-
Effectiveness of N-acetylcysteine in Treating Clinical Symptoms of Substance Abuse and Dependence: A Meta-analysis of Randomized Controlled Trials
Clinical Psychopharmacology and Neuroscience
2021 .01
-
Clinical Outcomes of Neoadjuvant Chemotherapy in Colorectal Cancer Patients With Synchronous Resectable Liver Metastasis: A Propensity Score Matching Analysis
Annals of Coloproctology
2021 .08
-
Predicting Successful Conservative Surgery after Neoadjuvant Chemotherapy in Hormone Receptor-Positive, HER2-Negative Breast Cancer
Journal of Breast Disease
2018 .01
-
Incidence of gastrointestinal perforation associated with bevacizumab in combination with neoadjuvant chemotherapy as first- line treatment of advanced ovarian, fallopian tube, or peritoneal cancer: analysis of a Japanese healthcare claims database
Journal of Gynecologic Oncology
2022 .11
-
The Prognosis and the Role of Adjuvant Chemotherapy for Node-Positive Bladder Cancer Treated with Neoadjuvant Chemotherapy Followed by Surgery
Cancer Research and Treatment
2022 .01
최근 본 자료
댓글(0)
0